Home
Scholarly Works
CHOICE OF ECBOLIC AND THE MORBIDITY OF DAY‐CASE...
Journal article

CHOICE OF ECBOLIC AND THE MORBIDITY OF DAY‐CASE TERMINATIONS OF PREGNANCY

Abstract

In 103 women admitted for out-patient vaginal terminations of pregnancy, the relation was investigated between the use of ecbolics and blood loss, vomiting and other side effects. Patient self-rating was incorporated in the study for comparative purposes. Use of a combined preparation of oxytocin and ergometrine resulted in the lowest blood losses. Ergometrine administered alone was associated with immediate nausea and vomiting but no delayed effects. Seven days after abortion, 35% of the women were still complaining of vaginal bleeding, although in most the volume was low.

Authors

Garrioch DB; Gilbert JR; Plantevin OM

Journal

BJOG An International Journal of Obstetrics & Gynaecology, Vol. 88, No. 10, pp. 1029–1032

Publisher

Wiley

Publication Date

October 1, 1981

DOI

10.1111/j.1471-0528.1981.tb01692.x

ISSN

1470-0328

Contact the Experts team